BIOCARTIS

In News

Press Release Biocartis NV: Biocartis Welcomes Ben Svarczkopf as Senior Vice President of Global Marketing - GlobeNewswire

GlobeNewswire - Jun 17, 2025

Biocartis Launches qPCR POLE/POLD1 Mutational Assay - Oncology Nursing News

Oncology Nursing News - Apr 04, 2025

Biocartis’ EGFR Mutation Test gains IVDR Class C CDx certification - Medical Device Network

Medical Device Network - Jun 02, 2025

Ben Svarczkopf - PharmaTimes

PharmaTimes - Jun 23, 2025

Press Release Biocartis NV: Biocartis announces new data on early CAR-T vector load assessment with Idylla™ presented at ASTCT: A Potential Breakthrough in LBCL Treatment Monitoring - GlobeNewswire

GlobeNewswire - Feb 14, 2025

Randy Polonsky Named CFO at Biocartis - Medical Product Outsourcing

Medical Product Outsourcing - Dec 10, 2024

Michael Korn has joined Biocartis NV as its Chief Medical and Scientific Officer - Oncodaily

Oncodaily - Aug 16, 2024

Press Release Biocartis NV: Biocartis Announces IVDR Class C CDx Certification of the Idylla™ EGFR Mutation Test - GlobeNewswire

GlobeNewswire - Jun 02, 2025

DC Advisory advised creditors on the EUR 200M+ comprehensive recapitalization of Biocartis Group NV - DC Advisory

DC Advisory - Feb 01, 2023

Biocartis Introduces Influenza-Respiratory Virus Panel on Idylla Platform - respiratory-therapy.com

respiratory-therapy.com - Nov 09, 2023

Biocartis starts European commercialization of liver cancer test - Labiotech.eu

Labiotech.eu - Oct 10, 2022

Genomic Health and Biocartis Announce Agreement to Develop an Idylla™ IVD Oncotype DX® Breast Cancer Test to Broaden Global Patient Access - PR Newswire

PR Newswire - Sep 13, 2017

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.